Chloe Orkin, MBChB, FRCP, MD, discusses CROI 2019 data on HCV treatment access and potential impacts on HCV elimination and vertical transmission.
Expert preview summary of key new data from CROI 2019, including phase III DISCOVER, ATLAS, FLAIR, and DAWNING trials, and weight gain with INSTIs
Expert commentary from Dr. Susanna Naggie on how to manage drug–drug interactions between ART and HCV regimens during HCV/HIV coinfection.
Expert commentary from Dr. Annie Luetkemeyer on clinically relevant drug–drug interactions with direct-acting antivirals (DAAs) in PLWH
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.